Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CPHI
CPHI logo

CPHI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy China Pharma Holdings Inc (CPHI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.660
1 Day change
-2.93%
52 Week Range
2.030
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CPHI is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a weak technical setup, no bullish proprietary trading signal, no supportive news catalyst, and no meaningful evidence of strong institutional or insider accumulation. Even though the price is near pivot support and short-term pattern data suggests some upside, the broader trend remains unfavorable and does not justify a confident long-term entry today.

Technical Analysis

The technical picture is bearish overall. MACD histogram is negative at -0.00666, showing weak momentum. RSI_6 at 59.447 is neutral and does not indicate an oversold bargain. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, which typically signals a downtrend or weak recovery attempt rather than a strong bullish reversal. Price at 0.7101 is essentially at the pivot level of 0.711, with resistance at 0.809 and 0.87, and support at 0.613 and 0.552. This suggests limited upside confirmation and meaningful downside risk if support fails. The short-term pattern model suggests possible modest gains, but the broader trend still looks weak.

Positive Catalysts

  • No news in the recent week. The only mildly positive item is the pattern-based probability model suggesting a possible short-term move higher over the next day, week, and month. Price is also trading close to the pivot level, which may offer a tactical bounce opportunity.

Neutral/Negative Catalysts

  • No recent news catalysts, no significant hedge fund activity, no insider buying trend, no recent congress trading data, and no proprietary buy signal from AI Stock Picker or SwingMax. The technical trend is bearish and the market structure does not show strong accumulation. Financial data was unavailable due to an error, so there is no confirmation of improving fundamentals.

Financial Performance

Financial snapshot data was unavailable due to an error, so the latest quarter performance cannot be assessed. As a result, there is no evidence provided of revenue growth, margin improvement, or earnings momentum for the latest quarter season.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided. Based on the available information, Wall Street sentiment cannot be called bullish. The pros view is weak because there are no supportive upgrades, target raises, or positive catalysts. The cons view dominates due to bearish technicals, absent news flow, and neutral trading trends from insiders and hedge funds.

Wall Street analysts forecast CPHI stock price to rise
Analyst Rating
0
Wall Street analysts forecast CPHI stock price to rise
Buy
Hold
Sell
0
Current: 0.683
sliders
Low
0
Averages
0
High
0
0
Current: 0.683
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch